Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8.74	12.62	13.16	63.46	16.46
Short-Term Investments	43.22	14.53	29.14	5.99	27.8
Cash & Short-Term Investments	51.96	27.15	42.3	69.45	44.26
Cash Growth	91.40%	-35.82%	-39.09%	56.92%	-43.24%
Accounts Receivable	0.08	0.03	0.59	0.51	-
Other Receivables	0.14	0.04	0.05	0.03	0.09
Receivables	0.22	0.06	0.63	0.54	0.09
Prepaid Expenses	0.47	0.38	0.43	0.45	0.4
Other Current Assets	1.76	0.37	0.29	0.87	0.59
Total Current Assets	54.41	27.96	43.66	71.31	45.34
Property, Plant & Equipment	1.33	1.39	2.57	3.64	2.55
Long-Term Investments	12.54	16.12	21.88	34.27	37.23
Other Long-Term Assets	0.63	0.09	0.13	0.24	0.41
Total Assets	68.91	45.55	68.24	109.46	85.53
Accounts Payable	2.58	1.53	1.98	1.57	3.47
Accrued Expenses	3.44	3.73	7.39	6.96	7.42
Current Portion of Leases	0.19	1.37	1.23	1.05	1.08
Other Current Liabilities	29.2	0.25	0.16	0.12	0.18
Total Current Liabilities	35.4	6.87	10.75	9.69	12.15
Long-Term Leases	0.94	-	1.37	2.6	1.23
Total Liabilities	36.34	6.87	12.13	12.29	13.38
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	430.86	374.36	364.36	361.67	295.28
Retained Earnings	-397.01	-334.72	-307.69	-266.38	-223.14
Comprehensive Income & Other	-1.29	-0.97	-0.56	1.87	0
Total Common Equity	32.57	38.68	56.12	97.16	72.15
Shareholders' Equity	32.57	38.68	56.12	97.16	72.15
Total Liabilities & Equity	68.91	45.55	68.24	109.46	85.53
Total Debt	1.12	1.37	2.6	3.65	2.31
Net Cash (Debt)	50.84	25.78	39.7	65.8	41.95
Net Cash Growth	97.25%	-35.08%	-39.67%	56.87%	-43.91%
Net Cash Per Share	0.83	0.54	0.85	1.57	1.42
Filing Date Shares Outstanding	68.14	49.04	46.57	46.55	38.31
Total Common Shares Outstanding	67.9	49.04	46.55	46.55	28.37
Working Capital	19.01	21.09	32.91	61.62	33.19
Book Value Per Share	0.48	0.79	1.21	2.09	2.54
Tangible Book Value	32.57	38.68	56.12	97.16	72.15
Tangible Book Value Per Share	0.48	0.79	1.21	2.09	2.54
Machinery	2.69	2.85	2.82	2.62	2.61
Leasehold Improvements	2.08	2.08	2.08	2.08	2.08

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q